跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OTIXAL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OTIXAL
Authorized
STANDARD
OTIXAL
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
103ac55dc3699b1e
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
103ac55dc3699b1e
Drug Approval Canada Name
OTIXAL
Product Name
OTIXAL
Status
Marketed
Status Date
2023-01-25
Original Market Date
2017-05-08
Din
02459655
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Otic
Schedule
Prescription
Ahfs
52:08.08
Atc Original
S02CA05 FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES
Atc Name
s 02 ca 05
Aig Number
0258670001
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
FLUOCINOLONE ACETONIDE
0.025 % / W/V
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
0.3 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
103ac55dc3699b1e
Type
Standard
Back to Health Canada Approvals